scispace - formally typeset
R

Ryann E. Swale

Researcher at University of California, Santa Cruz

Publications -  5
Citations -  498

Ryann E. Swale is an academic researcher from University of California, Santa Cruz. The author has contributed to research in topics: Virus & Embryonic morphogenesis. The author has an hindex of 5, co-authored 5 publications receiving 479 citations. Previous affiliations of Ryann E. Swale include Novartis.

Papers
More filters
Journal ArticleDOI

Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies

TL;DR: The large number of antibodies obtained from the bone marrow of five survivors of the recent H5N1 avian influenza outbreak in Turkey provide a detailed immunochemical analysis of individual human solutions to virus neutralization in the setting of an actual virulent influenza outbreak.
Journal ArticleDOI

Protection from the 2009 H1N1 Pandemic Influenza by an Antibody from Combinatorial Survivor-Based Libraries

TL;DR: In vitro and in vivo activity of a human monoclonal antibody (A06) against two isolates of the 2009 H1N1 pandemic influenza virus demonstrate broad activity of the A06 antibody and its utility as an anti-influenza treatment option, even against newly evolved influenza strains to which there is limited immunity in the general population.
Journal ArticleDOI

The C. elegans peroxidasin PXN-2 is essential for embryonic morphogenesis and inhibits adult axon regeneration

TL;DR: It is found that PXN-2 is essential for specific stages of embryonic morphogenesis and muscle-epidermal attachment, and is also required postembryonically for basement membrane integrity, and a new role for peroxidasins as extracellular inhibitors of axonal regeneration is revealed.
Journal ArticleDOI

The C. elegans F-spondin family protein SPON-1 maintains cell adhesion in neural and non-neural tissues

TL;DR: The F-spondin family of extracellular matrix proteins has been implicated in axon outgrowth, fasciculation and neuronal cell migration, as well as in the differentiation and proliferation of non-neuronal cells as discussed by the authors.
Journal ArticleDOI

Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitors.

TL;DR: A macrocyclic linkage of the P1 and P3 residues, and the subsequent structure-based optimization of the macrocycle conformation and size led to the identification of a potent biochemical inhibitor 10 with sub-micromolar antiviral activity.